Please cite:
Dimitra Karagkouni, Maria D. Paraskevopoulou, Serafeim Chatzopoulos, Ioannis S. Vlachos, Spyros Tastsoglou, Ilias Kanellos, Dimitris Papadimitriou, Ioannis Kavakiotis, Sofia Maniou, Giorgos Skoufos, Thanasis Vergoulis, Theodore Dalamagas, Artemis G. Hatzigeorgiou; DIANA-TarBase v8: a decade-long collection of experimentally supported miRNA–gene interactions, Nucleic Acids Research, gkx1141, https://doi.org/10.1093/nar/gkx1141
Bulk download:
We have updated the bulk download module, which simplifies the download process! Please find the new online form by following this link

hsa-miR-641


Loading... Please wait, this might take a few seconds...



Filters
Clear all
Interactions: 340, Experiments: (low: , high: , unknown: ) Cell lines: , Tissues: , Publications:
Gene name miRNA name Experiments
throughput
Publications Cell lines Tissues Pred. Score
TPT1 hsa-miR-641 low: 0 high: 2 1 1 1 -
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr13:45337513-45337530 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr13:45337513-45337530 HITS-CLIP POSITIVE DIRECT TarBase 7.0
SLC38A2 hsa-miR-641 low: 0 high: 2 2 2 2 -
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr12:46358714-46358727 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Skalsky Rebecca L. et al. 2012 IP N/A LCLBAC N/A N/A
Location Method Result Regulation Validation Type Source
chr12:46358832-46358854 PAR-CLIP POSITIVE DIRECT TarBase 7.0
SRSF1 hsa-miR-641 low: 0 high: 2 1 1 1 0.726
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr17:58005048-58005066 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr17:58005048-58005066 HITS-CLIP POSITIVE DIRECT TarBase 7.0
G3BP1 hsa-miR-641 low: 0 high: 2 2 2 2 0.925
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr5:151804996-151805014 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr5:151804421-151804428 HITS-CLIP POSITIVE DIRECT TarBase 7.0
EIF4EBP2 hsa-miR-641 low: 0 high: 2 2 2 2 0.761
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr10:70422397-70422421 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:emetine
Location Method Result Regulation Validation Type Source
chr10:70422388-70422413 HITS-CLIP POSITIVE DIRECT TarBase 7.0
UHMK1 hsa-miR-641 low: 0 high: 2 2 2 2 -
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr1:162523981-162524009 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr1:162523981-162524009 HITS-CLIP POSITIVE DIRECT TarBase 7.0
CAMK4 hsa-miR-641 low: 0 high: 2 2 2 2 0.910
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Skalsky Rebecca L. et al. 2012 IP N/A LCL35 N/A N/A
Location Method Result Regulation Validation Type Source
chr5:111486408-111486430 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:emetine
Location Method Result Regulation Validation Type Source
chr5:111492067-111492089 HITS-CLIP POSITIVE DIRECT TarBase 7.0
IGF2BP1 hsa-miR-641 low: 0 high: 2 1 1 1 -
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr17:49052626-49052647 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr17:49052626-49052647 HITS-CLIP POSITIVE DIRECT TarBase 7.0
YWHAB hsa-miR-641 low: 0 high: 2 2 2 2 0.968
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Skalsky Rebecca L. et al. 2012 IP N/A LCLBACD1 N/A N/A
Location Method Result Regulation Validation Type Source
chr20:44905053-44905080 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Kameswaran V et al. 2014 IP Pancreas BETA Cells N/A N/A
Location Method Result Regulation Validation Type Source
chr20:44908419-44908438 HITS-CLIP POSITIVE DIRECT TarBase 7.0
SOX11 hsa-miR-641 low: 0 high: 2 1 1 1 0.870
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr2:5694695-5694720 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr2:5694695-5694720 HITS-CLIP POSITIVE DIRECT TarBase 7.0
RPL23A hsa-miR-641 low: 0 high: 2 2 2 2 -
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Skalsky Rebecca L. et al. 2012 IP N/A LCL35 N/A N/A
Location Method Result Regulation Validation Type Source
chr17:28720577-28720596 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr17:28720577-28720596 HITS-CLIP POSITIVE DIRECT TarBase 7.0
TNKS2 hsa-miR-641 low: 0 high: 2 1 1 1 0.584
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr10:91865118-91865144 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr10:91865118-91865144 HITS-CLIP POSITIVE DIRECT TarBase 7.0
PSME3 hsa-miR-641 low: 0 high: 2 1 1 1 0.518
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr17:42841884-42841902 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr17:42841884-42841902 HITS-CLIP POSITIVE DIRECT TarBase 7.0
DYNC1LI2 hsa-miR-641 low: 0 high: 2 1 1 1 -
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr16:66732239-66732262 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr16:66732016-66732041 HITS-CLIP POSITIVE DIRECT TarBase 7.0
LONRF1 hsa-miR-641 low: 0 high: 2 1 1 1 -
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr8:12722518-12722538 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr8:12722518-12722538 HITS-CLIP POSITIVE DIRECT TarBase 7.0
SEPT2 hsa-miR-641 low: 0 high: 2 1 1 1 -
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr2:241352155-241352178 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr2:241352155-241352178 HITS-CLIP POSITIVE DIRECT TarBase 7.0
DDX3X hsa-miR-641 low: 0 high: 1 1 1 1 0.928
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chrX:41348250-41348273 HITS-CLIP POSITIVE DIRECT TarBase 7.0
DEPDC1B hsa-miR-641 low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr5:60597214-60597235 HITS-CLIP POSITIVE DIRECT TarBase 7.0
ID4 hsa-miR-641 low: 0 high: 1 1 1 1 0.788
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr6:19840665-19840681 HITS-CLIP POSITIVE DIRECT TarBase 7.0
MSL3 hsa-miR-641 low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chrX:11760866-11760893 HITS-CLIP POSITIVE DIRECT TarBase 7.0